Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Reflexion Medical is a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT). Their flagship product, the X1 platform, is designed to overcome the limitations of current radiotherapy by using the tumor's own emissions to continuously guide treatment. This technology aims to enable more precise targeting, especially for metastatic disease, potentially treating multiple tumors in the same session and adapting to tumor motion. Reflexion's mission is to expand the use of stereotactic body radiation therapy (SBRT) to all stages of cancer, offering new hope to patients with advanced cancer.
The Hayward facility serves as the central hub for Reflexion Medical's research and development, engineering, manufacturing of their X1 radiotherapy system, and corporate operations.
The headquarters likely includes state-of-the-art R&D laboratories, cleanroom facilities for medical device assembly, and modern office spaces designed to foster collaboration and innovation. Specific architectural details are proprietary.
Reflexion Medical's work culture is likely mission-driven, with a strong emphasis on innovation, scientific rigor, and collaboration. Employees are passionate about advancing cancer treatment and making a tangible impact on patients' lives. The environment is expected to be dynamic and fast-paced, characteristic of a growth-stage medical technology company.
This location is strategically important due to its proximity to talent from leading universities, access to a rich ecosystem of suppliers and partners in the biotech and medtech industries, and a supportive environment for innovation.
While Reflexion Medical is headquartered in the USA, its technology has global potential. The company is actively working to expand its reach by seeking regulatory approvals and establishing partnerships in key international markets, including Europe and Asia. Their global functions supported include sales, clinical support, regulatory affairs, and distribution partnerships, tailored to meet the specific needs of each region they enter.
2525 West Winton Avenue
Hayward
California
USA
Address: N/A (Field-based personnel)
To offer localized installation, training, maintenance, and sales support for the X1 system, ensuring optimal performance and customer satisfaction in various healthcare markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, RefleXion Medical' leadership includes:
RefleXion Medical has been backed by several prominent investors over the years, including:
In the past 12-18 months, Reflexion Medical has seen some key executive appointments to strengthen its commercialization and operational capabilities. For instance, Dave Rosa joined as CCO in late 2023. Specific exits are not always publicly announced unless material.
Discover the tools RefleXion Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Reflexion Medical likely uses a standard corporate email format, commonly [first_initial][last]@[domain] or [first].[last]@[domain]. Based on publicly available information and common industry practices, the most probable format is the first initial followed by the last name.
flast@reflexion.com (e.g., jdoe@reflexion.com)
Format
tpowell@reflexion.com
Example
85%
Success rate
Reflexion Medical Press Release • May 21, 2024
Reflexion Medical announced the first patient treatments in its PREMIER registry, a prospective, real-world evidence clinical trial evaluating the impact of SCINTIX biology-guided radiotherapy for patients with oligometastatic disease. This marks a significant step in gathering data on SCINTIX therapy's effectiveness....more
Reflexion Medical Press Release • February 27, 2024
Reflexion Medical announced the first prostate cancer patients have been treated with SCINTIX® biology-guided radiotherapy. This expansion into prostate cancer treatment demonstrates the versatility of the X1 platform in treating various cancer types....more
Business Wire • October 26, 2023
Reflexion Medical announced the appointment of Dave Rosa as Chief Commercial Officer. Rosa brings extensive experience in commercializing innovative medical technologies and will lead Reflexion's global commercial strategy for the X1 platform....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including RefleXion Medical, are just a search away.